Curaleaf
(TSX) CURA
Curaleaf Financials at a Glance
Market Cap
$2.60B
Revenue (TTM)
$1.28B
Net Income (TTM)
$243.85M
EPS (TTM)
$-0.44
P/E Ratio
-7.57
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$3.36
Volume
1,027,092
Open
$3.01
Price
$3.36
Volume
1,027,092
Open
$3.01
Previous Close
$3.36
Daily Range
$3.01 - $3.39
52-Week Range
$0.99 - $6.97
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$3.36
Volume
1,027,092
Open
$3.01
Previous Close
$3.36
Daily Range
$3.01 - $3.39
52-Week Range
$0.99 - $6.97
CURA News
3 Hot Growth Stocks to Buy Now
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Curaleaf
Industry
Pharmaceuticals
Sector
Health CareCEO
Boris Alexis Jordan
Website
www.curaleaf.comHeadquarters
New York City, NY 10170, US
CURA Financials
Key Financial Metrics (TTM)
Gross Margin
41%
Operating Margin
1%
Net Income Margin
-18%
Return on Equity
-27%
Return on Capital
1%
Return on Assets
-8%
Earnings Yield
-13.21%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.60B
Shares Outstanding
774.94M
Volume
1.03M
Short Interest
0.00%
Avg. Volume
574.60K
Financials (TTM)
Gross Profit
$498.20M
Operating Income
$25.90M
EBITDA
$169.76M
Operating Cash Flow
$140.35M
Capital Expenditure
$64.55M
Free Cash Flow
$75.80M
Cash & ST Invst.
$101.39M
Total Debt
$1.04B
Curaleaf Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$338.19M
+2.2%
Gross Profit
$128.35M
-18.4%
Gross Margin
37.95%
N/A
Market Cap
$2.60B
N/A
Market Cap/Employee
$471.79K
N/A
Employees
5,519
N/A
Net Income
$60.74M
+21.7%
EBITDA
$38.89M
+49.2%
Quarterly Fundamentals
Net Cash
$933.83M
-22.7%
Accounts Receivable
$80.82M
+21.6%
Inventory
$0.00
-100.0%
Long Term Debt
$960.86M
+32.8%
Short Term Debt
$67.25M
-48.3%
Return on Assets
-8.19%
N/A
Return on Invested Capital
0.71%
N/A
Free Cash Flow
$27.24M
+37.7%
Operating Cash Flow
$43.06M
-8.5%